Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia

JAMA Oncol. 2018 Aug 1;4(8):1110-1111. doi: 10.1001/jamaoncol.2017.4724.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aminopyridines
  • Humans
  • Isocitrate Dehydrogenase*
  • Leukemia, Myeloid, Acute*
  • Triazines

Substances

  • Aminopyridines
  • Triazines
  • enasidenib
  • Isocitrate Dehydrogenase